Expertise in
17
conditions

Dr. Godson I. Oguchi

Infectious Disease
AdventHealth Wound Care Orange City
1061 Medical Center Dr Ste 101, 
Orange City, FL 
Accepting New Patients
Offers Telehealth
Expertise in
17
conditions
AdventHealth Wound Care Orange City
1061 Medical Center Dr Ste 101, 
Orange City, FL 

Overview

Godson Oguchi is an Infectious Disease provider practicing medicine in Orange City, Florida.

Dr. Oguchi is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Cellulitis, Osteomyelitis, COVID-19, and Lymphangitis.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 6 clinical trials. Dr. Oguchi is currently accepting new patients.

Specialties

Infectious Disease

Licenses

Internal Medicine in FL

Hospital Affiliations

Adventhealth Orlando
Adventhealth Fish Memorial
Adventhealth Daytona Beach
Adventhealth Deland

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Florida Health
  • HMO
  • POS
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

AdventHealth Wound Care Orange City
1061 Medical Center Dr Ste 101, Orange City, FL 32763

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A 2-Part, 2-Arm, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study on the Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
A 2-Part, 2-Arm, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study on the Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
Enrollment Status: Terminated
Publish Date: October 08, 2024
Intervention Type: Drug
Study Drug: Niclosamide
Study Phase: Phase 2
A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
Enrollment Status: Completed
Publish Date: May 30, 2024
Intervention Type: Drug
Study Drugs: Gepotidacin, Ceftriaxone, Azithromycin
Study Phase: Phase 3
An Open-label, Non-comparator, Multicenter Study to Describe the Pharmacokinetics (PK), Pharmacodynamics (PD; Viral Load) and Safety Following a Single Intravenous or Intramuscular Dose of Sotrovimab in Pediatric Participants With Mild to Moderate COVID-19 at High Risk of Disease Progression
An Open-label, Non-comparator, Multicenter Study to Describe the Pharmacokinetics (PK), Pharmacodynamics (PD; Viral Load) and Safety Following a Single Intravenous or Intramuscular Dose of Sotrovimab in Pediatric Participants With Mild to Moderate COVID-19 at High Risk of Disease Progression
Enrollment Status: Terminated
Publish Date: January 03, 2024
Intervention Type: Biological
Study Drug: Sotrovimab
Study Phase: Phase 2
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: June 22, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3
View 5 Less Clinical Trials

3 Total Publications

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
Journal: The New England journal of medicine
Published: December 22, 2021
Similar Doctors
Expertise in
29
conditions
Dr. Joseph T. Katta
Infectious Disease
Expertise in
29
conditions
Dr. Joseph T. Katta
Infectious Disease
Referral may be required

Infectious Disease Consultants MD PA

685 Palm Springs Dr Ste 2A, 
Altamonte Springs, FL 
 (19.6 miles away)
407-830-5577
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Katta is an Infectious Disease provider practicing medicine in Altamonte Springs, Florida. Dr. Katta is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Sepsis, Hospital-Acquired Pneumonia, Lymphangitis, and Osteomyelitis. Dr. Katta is board certified in American Board Of Internal Medicine. Dr. Katta is currently accepting new patients.

Expertise in
36
conditions
Dr. Javier E. Marinez
Infectious Disease
Expertise in
36
conditions
Dr. Javier E. Marinez
Infectious Disease
Referral may be required

Infectious Disease Consultants MD PA

685 Palm Springs Dr Ste 2A, 
Altamonte Springs, FL 
 (19.6 miles away)
407-830-5577
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Javier Marinez is an Infectious Disease provider practicing medicine in Altamonte Springs, Florida. Dr. Marinez is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Sepsis, Hospital-Acquired Pneumonia, Lymphangitis, and Pneumonia. Dr. Marinez is board certified in American Board Of Internal Medicine. Dr. Marinez is currently accepting new patients.

Expertise in
33
conditions
Dr. Anibal J. Maldonado
Infectious Disease
Expertise in
33
conditions
Dr. Anibal J. Maldonado
Infectious Disease
Referral may be required

Infectious Disease Consultants MD PA

685 Palm Springs Dr Ste 2A, 
Altamonte Springs, FL 
 (19.6 miles away)
407-830-5577
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Anibal Maldonado is an Infectious Disease provider practicing medicine in Altamonte Springs, Florida. Dr. Maldonado is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Hospital-Acquired Pneumonia, Sepsis, Pneumonia, and Lymphangitis. Dr. Maldonado is board certified in American Board Of Internal Medicine. Dr. Maldonado is currently accepting new patients.

Frequently Asked Questions about Dr. Godson I. Oguchi

How do I make an appointment with Dr. Godson I. Oguchi?

You can book an appointment with Dr. Godson I. Oguchi by calling their office at 386-228-0661. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Godson I. Oguchi a top-rated expert for Cellulitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Godson I. Oguchi is classified as an Distinguished expert for Cellulitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Godson I. Oguchi specialize in?

While Dr. Godson I. Oguchi is a Infectious Disease, they have specific expertise in Cellulitis, Osteomyelitis, and COVID-19. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Godson I. Oguchi participate in research or clinical trials?

Yes. Dr. Godson I. Oguchi has published 3 articles and abstracts on conditions like Cellulitis. You can view a list of Dr. Godson I. Oguchi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Godson I. Oguchi accept my insurance?

Dr. Godson I. Oguchi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 386-228-0661 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Oguchi's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 11 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile